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Summary The activity of y-glutamyltranspeptidase (yGT) (EC 2.3.2.2) was examined by histoenzymatic
labelling on frozen sections derived from normal breast tissue, benign lesions and carcinomas. In biopsies from
normal tissue and benign lesions, labelling was very intense in lumina and in the apical pole of the cells lining
the lumina whilst in the cytoplasm it was slightly positive. In 34 out of 70 carcinomas, yGT activity was either
undetectable or slightly positive while in the remaining 36 there was intense activity. Statistical examination of
the results revealed (1) no obvious correlation of yGT activity with histological grade of the tumour,
progesterone receptor content or classification of patients by pre- or postmenopausal status. (2) A good
correlation between yGT activity and the following unfavourable prognostic signs: lymph node metastases and
absence of oestradiol receptors. Patients with yGT-negative tumours may have a more favourable prognosis
than those with yGT-positive tumours.
The activity of the enzyme y-glutamyltranspeptidase
(yGT) has been measured by both biochemical and
histoenzymatic assays in human and animal tissues.
Activity is elevated in renal tubules, pancreatic
acinar cells and in epithelial cells of the rat jejunum
(Rutenburg et al., 1969; Marathe et al., 1979). An
increase in yGT activity has also been detected in
neoplastic tissue compared to that in the
corresponding normal tissue, as exemplified by the
rat mammary gland (Jaken & Mason, 1978), benign
papilloma and squamous cell carcinoma in mouse
skin (De Young et al., 1978; Klein-Szanto et al.,
1983). In the case of rat hepatoma, not only is there
an increase in activity, but the increase is observed
at an early stage in preneoplastic hepatocytes (Fiala
et al., 1976; Harada et al., 1976; Cameron et al.,
1978; Hirota & Williams, 1979).
Increased yGT activity in the sera of cancer
patients is a good marker of metastases in the liver
of patients with primary tumours of the lung,
breast and digestive tract (Ranson et al., 1973;
Cooper et al., 1975; Almersjo et al., 1976; Munjal
et al., 1976; Beck et al., 1979). In the mammary
gland, yGT activity can be modulated by prolactin,
oestradiol and progesterone (Puente et al., 1979;
Pocius et al., 1980). Since breast tumours contain
different concentrations of oestrogen and
progesterone receptors, it seemed reasonable to
determine whether there was any relationship
between yGT activity of breast carcinomas and their
receptor content. To do this, the histoenzymatic
method was chosen since it permitted enzyme
activity to be assessed in the tumour tissue itself,
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whereas the biochemical technique would have
given an overall activity of tumour and surrounding
tissue.
A similar study was reported by Levine et al.
(1983), but this work was performed in absence of
a control for the specificity of the yGT reaction.
This specificity can easily be shown using serine-
borate, known to be an inhibitor of yGT activity
(Tate & Meister, 1978). In the present study, yGT
activity in breast tumours was examined and the
specificity of the staining controlled by serine-
borate. Furthermore, a statistical examination of
the results was performed in order to investigate if
yGT activity could have prognostic value.
Materials and methods
Specimens
The study was carried out on biopsies of mammary
tumours obtained from patients undergoing surgery
at the Centre Leon Berard between May 1983 and
August 1984. Tumours were typed according to the
World Health Organization classification (O.M.S.,
1981). The study comprised 27 benign and 70
malignant tumours, as well as 5 biopsies from
histologically normal tissue taken at some distance
from the tumour. Histological grading of the
carcinomas was established as described by Bloom
and Richardson (1957). In addition, the active cell
population, defined as the ratio of tumour cells to
stroma, was evaluated by eye as accurately as
possible for each carcinoma.
Histoenzymatic determination ofyGT activity
A fragment of each tumour obtained at surgery was
© The Macmillan Press Ltd., 1986638 S. BARD et al.
immediately frozen in liquid nitrogen. Frozen
sections (5pm) were labelled according to the
method described by Rutenburg et al., (1969):
sections were incubated at room temperature for
30min in a solution containing 1 ml of a substrate
solution (2.5 mg y-glutamyl-4-methoxy-2-naphtyla-
mideml- I distilled water), 5.0ml Tris Buffer (0.1 M)
pH 7.4, 14ml 0.85% NaCl, 10mg glycylglycine and
10mg Fast Blue BBN. The specificity of the
reaction was controlled by incubating sections in
the same medium described above but containing
0.5mgml -1 of L. serine and 3.8mgml -1 of sodium
borate, as potent inhibitors of the enzyme (Tate &
Meister, 1978). For each tumour yGT labelling was
performed on 3 sections. For each section examined
for yGT activity another section of the same series
was stained with haematoxylin-phloxin-saffron for
histological examination. Microscopic observation
and photographs were made on the same day.
Measurement ofoestrogen andprogesterone
receptors
Oestrogen and progesterone receptors in the
tumours were determined by methods previously
described (EORTC Breast Cancer Cooperative
Group, 1973; Horwitz & McGuire, 1975). The
carcinomas were considered positive when their
receptor level was > 10fmolmg- 1 protein, as
generally accepted (Hawkins et al., 1980).
Measurement ofserum yGT
Serum yGT was determined using an auto-analyser,
ASTRA Systems, Beckman instruments (Normal
range 7-641Ul-1).
Statistical methods
Correlations were attempted between in situ yGT
activity and histological grade, the active cell
population, lymph node invasion, oestradiol
receptor (ER) content, progesterone receptor (PGR)
content, serum yGT levels and pre- or post-
menopausal status.
Qualitative correlations were compared using the
Chi Square test with Yates correction. Analysis of
variance was used to study quantitative variables.
All tests were performed with a two side rule and
0.05 significance level. Numerical data are
expressed as mean (±s.e.).
Results
Evidencefor yGT activity
yGT activity was visualised in sections by the
presence of a granular orange-red precipitate.
Controls incubated in the presence of L. serine and
sodium borate showed no coloured deposit.
yGT activity in benign tumours
Figure 1 shows the typical enzyme labelling pattern
obtained with sections from benign tumours. In this
category, consisting of 9 fibroadenomas, 3 benign
phyllodes tumours and 15 fibrocystic diseases,
enzyme activity was always found to be distributed
as follows: only epithelial cells were positive.
Connective tissue showed no activity. The most
intense staining was localised in the lumina of ducts
and lobules, and in the apical pole of the cells
lining the lumina. In the non apical region of the
cytoplasm, labelling was less intense and more
evenly distributed.
Figure 1 Benign lesion (Fibrocystic disease) stained
for yGT activity. The labelling is intense in the apical
pole of the cells lining the lumina, and inside the
lumina. Non apical cytoplasm is faintly positive.
(x 150)
yGT activity in normal tissue
In sections from normal tissue the distribution of
enzyme activity was identical to that described for
benign tumours (Figure 2).
yGT activity in malignant tissue
Of 70 carcinomas examined, 4 were infiltrating
lobular carcinomas and 66 were infiltrating ductal
carcinomas. Whereas the staining pattern of the
benign tumours was similar from one tumour to the
next, with carcinomas it was heterogeneous.
Carcinomas were either: (i) positive with
cytoplasmic staining present in 100% of all the
tumour cells of the biopsy (Figure 3). The intensity
of positive staining was variable from one tumour
to the other; or (ii) totally negative, without
labelling, or with a labelling pattern not
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Figure 2 yGT activity in normal breast tissue. The
staining is intense in the lumina and apical pole of
epithelial cells. ( x 150)
Figure 3 yGT activity in a poorly differentiated
ductal carcinoma. Carcinoma cells are strongly
positive. (x 150)
characteristic of positive cells in that it was
restricted to some rare specks (Figure 4); (iii)
heterogeneously positive with both positive and
negative cells in the same tumour. In cases of
heterogeneous labelling, positive cells were always
grouped in distinct areas, and not dispersed
throughout the tumour. In some well-differentiated
carcinomas, staining was more typical of that found
in benign tumours in that activity was greater at the
apical pole of the cells lining the lumina (Figure 5).
However, no positive staining was seen inside the
lumina.
Statistical analysis
Malignant tumours were subdivided into 2 groups:
(i) yGT positive - if 50-100% of cancer cells
showed intense labelling. The ratio of
positive/negative cells was estimated by counting
the cell population as accurately as possible. This
group comprised 36 tumours (51.4%).
Figure 4 Poorly differentiated ductal carcinoma in
which yGT activity is negligible, the staining pattern being restricted to some rare specks. ( x 150)
Figure 5 Well-differentiated ductal carcinoma. yGT activity is elevated in cells lining the lumina. ( x 150)
(ii) yGT negative - if enzyme activity was
undetected, or with a staining pattern restricted to
rare specks, or present in <50% of cancer cells.
This group comprised 34 tumours (48.6%).
Table I shows the relationship between yGT activity and histological grade. Out of 38 grade 1
tumours, 20 were positive, and of 25 grade 2, 12
were positive. There was no obvious correlation
between yGT activity and the histological grade of
the carcinoma.
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The active cell population was 48.2% in the yGT
positive group, and 44% in the yGT negative.
Again no correlation was apparent here. However,
when compared with the presence of lymph node
metastases (Table II), tumours with yGT activity
showed a significant correlation (P<0.05). Of the
other criteria examined for the existence of a
possible relationship with yGT, viz. pre- or post-
menopausal status, ER and PGR content, serum
yGT levels, Table III shows that there was no
correlation with menopause. As regards ER and
PGR, it is apparent from Table IV that the
relationship between the absence of ER and the
presence of yGT is significant (P-0.05). This is not
the case with PGR. yGT positivity or negativity is
equally distributed between the PGR+ group or
the PGR- group (Table IV). The range of yGT
circulating levels was 9-40IU -1 for yGT negative
tumours and 5-199IU1- I for yGT positive
tumours. The mean values of serum yGT were
33.93+5.84IUl1 and 17.91 +2.921UPl- for yGT
positive and negative tumours respectively. If we
exclude the 3 patients whose serum yGT levels
were above the normal range (64IU -1) we were
left with an average value of 24.82+3.41 IU1 1
which is not significantly different from that
(17.91+2.921UI-1) in patients with yGT negative
tumours.
Table II Relationship between yGT activity
and lymph node invasion
yGT' yGT-
Absence of lymph
node invasion 9 17
Presence of lymph
node metastases 27 17
X2=4.67 P<0.05
Table III Relationship between yGT activity







A histoenzymatic analysis of human mammary
tissue for yGT activity has provided evidence for a
difference between normal and benign tissue on the
one hand and malignant tumours on the other.
Table IV Relationship between yGT
activity and oestradiol receptors (ER)









Indeed, as previously stated, the staining pattern of
normal and benign tissue was similar from one
sample to the next whereas it was heterogeneous in
carcinomas. Further, the distribution of enzyme
activity was similar in normal and benign tissue in
that it was confined to the lumina of the ducts and
lobules, and to the apical pole of epithelial cells
with little or no staining of the cytoplasm. On the
contrary, the cytoplasm of certain malignant
carcinomas showed intense activity though the
intensity varied from one tumour to the next. In
other carcinomas activity was greatly reduced or
almost negligible. This variation in yGT activity in
human mammary carcinomas had been previously
reported by Levine et al. (1983) who noted a
tendency for the more poorly differentiated
carcinomas (grades 2 and 3) to have a weaker yGT
activity than grade 1 tumours. We could find no
supportive evidence among our observations on 70
different tumours. In fact there were no obvious
histopathological differences detectable by light
microscopic examination between yGT+ and yGT-
tumours. Possible reasons for this discrepancy may
be that the authors did not control the specificity of
the yGT reaction with serine-borate as we have
done here and that they did not perform a
statistical examination of their results. They also
had a distribution of carcinomas between the 3
grades different from ours. The tumours used in
this study are indeed biased in favour of grade 1
tumours according to the Bloom and Richardson
classification. However they do not represent the
overall tumour incidence from patients attending
the breast cancer clinic. This incidence was 25%
grade 1, 45% grade 2 and 30% grade 3, over the
period of the study. The bias is due to the
availability of biopsy material at surgery. The only
correlations which were statistically significant with
yGT activity were lymph node invasion, and the
absence of oestradiol receptors (ER-). As regards
the former, Nemoto et al. (1980) have shown that
lymph node invasion is an unfavourable prognostic
sign. As regards the latter, Knight et al. (1977) andyGT ACTIVITY IN HUMAN BREAST LESIONS 641
Rich et al. (1978) have also provided evidence
showing that patients with ER- tumours have a
less favourable prognosis than those with ER'
tumours. At the moment though, this latter result
should be interpreted with caution since the
progesterone receptor content seems to be of
greater prognostic value than that of ER (McGuire
& Clark, 1983; Saez et al., 1983). The functional
significance of yGT in tumour cells cannot be
determined from the results of the histoenzymatic
analysis reported here. However the role of this
enzyme in y-glutamyl amino acid transport is well
documented and recently Bridges and Meister
(1985) have suggested that the transport of y-
glutamyl amino acids is dependent on intracellular
glutathione levels. Further Osuji (1980) has also
shown that yGT has two amino acid transporting
sites. One can therefore speculate that the activity
in benign tissue may be a reflection of normal y-
glutamyl amino acid transport whereas in
carcinomas it may be a reflection of impairment in
intracellular glutathione metabolism which has also
been reported in some transformed cells (Meister &
Anderson, 1983). In connection with yGT itself,
circulating enzyme levels determined before
mastectomy were elevated in only 3 patients whose
tumours were yGT positive. Our inability to find a
significant correlation between tumour yGT
positivity and circulating yGT may be due to the
fact that our histoenzymatic analysis on yGT
positive tumours were performed on only 2 grade 3
tumours compared to 32 grade 1 and grade 2
tumours.
Based on the two above mentioned criteria viz.
lymph node invasion, and ER- tumours, yGT
positivity would appear to be an unfavourable
prognostic sign. The real value of the results
reported here will be tested only in a few years time
when survival rates between the two groups can be
compared.
Meanwhile, the simplicity and the rapidity of
the histoenzymatic method properly controlled
for enzyme specificity are two arguments in favour
of performing routine yGT determinations in
histological examinations of breast cancer.
We are indebted to Dr Simone Saez for helpful discussion
and for hormone receptor determinations. We thank Mr
Yves du Bois and Mr Alain Joubert for preparing the
illustrations, and Ms. Josiane Colonozet for typing the
manuscript.
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